Discover Selvita's Hit Identification services
17 Nov 2023In this product brochure, Selvita discusses its Hit Identification (HitID) services, aiming to provide high-quality compounds with confirmed activity against a biological target or phenotypic screen. The services utilize automated biochemical and cell-based assays, screening against a diverse collection of proprietary and commercial compound libraries. Selvita combines experimental screens with in-house virtual screening capabilities and employs dedicated scientists with extensive experience in HitID campaigns.
Related Products
Request Quote for All Products
In vivo pharmacology and toxicology
SelvitaSelvita’s in vivo team has long standing experience in the areas of infection, inflammation and fibrosis and has contributed to numerous preclinical and clinical candidates. Over 60 animal models in mice, rats, and rabbits are fully characterized and validated with clinically relevant pharmacological controls whereas in-depth expertise in translational biomarker selection and validation gives confidence in the smooth transition of the candidate molecule toward clinic.